Kansas City Cancer Center
Oncology
Dr. Amy C. Rabe practices Oncology. He studied medicine at University of Kansas School of Medicine. Rabe has written publications. He has 1 publication published with PubMed. The lastest publication is: 'Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients.' He accepts Medicare.
Publications
Procedures Preformed
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Kansas School of Medicine
Drug Facts
| NPI NUMBER |
|
1154399798 |
| NPPES Provider LastName |
|
RABE |
| NPPES Provider FirstName |
|
AMY |
| NPPES Provider ZIPCode |
|
662104045 |
| NPPES Provider State |
|
KS |
| Specialty Description |
|
Hematology/Oncology |
| Total Claim Count |
|
905.0 |
| Distinct Opioid Count |
|
3.0 |
| Opioid Claim Count |
|
54.0 |
| Percent Opioid Claims |
|
5.97 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1154399798 |
| Last Name Of The Provider |
RABE |
| First Name Of The Provider |
AMY |
| View All |
|
Doctor Directory | TOS | twitter | FB | Angel | blog
